SMTL ID : 2p2i.1 (1 other biounit)

Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 608: N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide(Non-covalent)

608.1: 22 residues within 4Å: Chain A: L.26, V.34, A.52, V.53, K.54, E.71, I.74, L.75, I.78, V.100, V.102, E.103, F.104, C.105, L.155, C.160, I.161, H.162, L.171, C.181, D.182, F.183 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:L.26, A:A.52, A:K.54, A:E.71, A:I.74, A:L.75, A:I.78, A:V.102, A:L.155, A:L.171, A:D.182, A:F.183 Hydrogen bonds: A:K.54, A:E.71, A:C.105, A:D.182, A:D.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hodous, B.L. et al., Evolution of a Highly Selective and Potent 2-(Pyridin-2-yl)-1,3,5-triazine Tie-2 Kinase Inhibitor. J.Med.Chem. (2007)

Release Date

2007-03-20

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence